Anti-Human IL-21R Reference Antibody (ATR-107, RUO) (HV076026)

Price(USD): $

Spec:

Number:

Overview

Catalog No.	HV076026
Description	Anti-Human CD360/IL21R (ATR-107) (HV076026) is a research-grade recombinant antibody targeting CD360. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivity	Human, Mouse
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG1-lambda
Clone ID	ATR-107
Expression system	Mammalian Cells
Clonality	Monoclonal
Target	IL21R, NILR, Interleukin-21 receptor, IL-21R, IL-21 receptor, CD360, Novel interleukin receptor
Endotoxin level	Please contact the lab for this information.
Purity	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	Q9HBE5
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	ATR-107, ATR107, ATR107
Background	Interleukin-21 receptor (CD360/IL21R) is a ~59 kDa protein. This is a receptor for interleukin-21.
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

Bioactivity

Detects Recombinant Human CD360/IL21R Protein, C-His (Cat No.: HV076011) in indirect ELISA.
Bioactivity

Detects Recombinant Mouse CD360/IL21R Protein, C-His (Cat No.: MV076011) in indirect ELISA.